Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Verona
Pharma
Verona earns FDA nod for potential blockbuster to treat COPD
Verona has earned an FDA approval for Ohtuvayre, a potential blockbuster to treat patients with COPD.
Kevin Dunleavy
Jun 26, 2024 6:26pm
FDA delays decision on Sanofi and Regeneron's Dupixent for COPD
May 31, 2024 9:30am
GlobalData, ICER weigh in on Verona's COPD drug ensifentrine
May 30, 2024 12:17pm